Celia
Arib
a,
Nadia
Bouchemal
a,
Maria
Barile
b,
Didier
Paleni
c,
Nadia
Djaker
a,
Nathalie
Dupont
a and
Jolanda
Spadavecchia
*a
aCNRS, UMR 7244, CSPBAT, Laboratoire de Chimie, Structures et Propriétés de Biomatériaux et d'Agents Thérapeutiques, Université Paris 13, Sorbonne Paris Nord, 1 Rue Chablis, 93000, Bobigny, France. E-mail: jolanda.spadavecchia@univ-paris13.fr
bDept. of Biosciences, Biotechnology and Biopharmaceutics, University of Bari “Aldo Moro”, Via Orabona, 470126, Bari, Italy
cBioEVEN Start-up, 75 Rue de Lourmel, 75015, Paris
First published on 7th August 2025
Expression of concern for ‘Flavin-adenine-dinucleotide gold complex nanoparticles: chemical modeling design, physico-chemical assessment and perspectives in nanomedicine’ by Celia Arib et al., Nanoscale Adv. 2021, 3, 6144–6156, https://doi.org/10.1039/D1NA00444A.
Nanoscale Advances is publishing this expression of concern in order to alert our readers that following the publication of a correction to this paper to update panels B and B1 in Fig. S3 (https://doi.org/10.1039/D3NA90084C), additional concerns have been raised regarding the reliability of Fig. 5, S1 and S3. An investigation is underway, and Sorbonne Paris Nord University and the CNRS have been requested to investigate the concerns.
An expression of concern will continue to be associated with the article until a final outcome is reached.
Jeremy Allen
31st July 2025
Executive Editor, Nanoscale Advances
This journal is © The Royal Society of Chemistry 2025 |